Oncology Central

100,000 Genomes Project: an interview with David Bentley

Professor Dame Sally Davies’s eighth independent report to government as Chief Medical Officer – Generation Genome – highlighted the vital role genetics and genomics will play in UK NHS healthcare and medicine. In this report she stated that cancer patients should be routinely offered DNA tests to help select the best treatments for them. Illumina, is a leading sequencing technology company and has a partnership with Genomics England working on the 100,000 Genomes Project. We recently spoke with Illumina’s Chief Scientist, David Bentley about his thoughts on the report and the implications the 100,000 Genomes Project may have for rare genetic diseases and cancer.

The UK Chief Medical Officer’s annual report 2016: Generation Genome, looks at how genomics can improve health and prevent ill-health. What are your thoughts on this report?

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.